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1. Introduction
  The mutant p53 gene and mdm2 gene are found in the 
majority of human tumor tissues, and the relationship 
between p53 and mdm2 has become the focus of studies. 
Few studies focuses on p53 and mdm2 in the oral mucosa 
leukoplakia. In this study RT-PCR and flow cytometric 
analysis were used to detect the mRNA of p53, mdm2 in 
patients with normal oral mucosa, simple oral leukoplakia, 
no-simple oral leukoplakia and leukoplakia cancer, to 
explore their role in the carcinogenesis of oral leukoplakia.
2. Materials and methods
2.1. Clinical data
  A total of 110 oral leukoplakia patients diagnosed by 
clinical and pathological examination were selected. There 
were 69 males and 41 females, aged from 23 to 83 years, 
with disease course from 2 months to 10 years. Standard of 
clinical manifestations and classification were according to 
the criteria by WHO in 1996, pathological classification was 
according to Pindborg criteria[1].
2.2. Reagents
  Trizol (Shanghai Sangon Biological Engineering Co., 
Ltd.), fluorescein isothiocyanate, lymphocyte separation 
medium (Langton Biotechnology Co., Ltd.), mouse anti-
human p53 monoclonal antibody, mouse anti-human 
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mdm2 monoclonal antibodies (Shanghai Sangon Biological 
Engineering Co., Ltd.), RT-PCR reagent kit (Wuhan Boster 
Biological Engineering Co., Ltd.), PCR thermal cycler (Bio-
Rad, USA), flow cytometry (Bio-Rad, USA).
2.3. Specimen collection
  Two days after admission, early morning fasting blood 
samples were obtained from the forearm vein of the patients 
then were placed in the heparinized tube.
2.4. RT-PCR detection of p53, mdm2 expression
  Specimens were removed from the -80 曟 refrigerator, and 
the total RNA was extracted by the instructions of Trizol 
reagent kit, to determine the quality and concentration of 
the extracted RNA. The volume of 2 毺g RNA was calculated 
according to the concentration. Reverse transcription was 
conducted in accordance with kit. The primers were as 
follows:
  p 5 3  p r i m e r s :  U p s t r e a m  5 - C T A A C C G C G G T
C C C T T C C C A G A A A A C C T A C - 3 ,  d o w n s t r e a m 
5-TACAGTCAGAGCCAACCTCAGGCG-3, a total of 409 bp.
  mdm2 primers: upstream 5’-AATCATCGGACTCAGGTA-3’, 
downstream 5’-CTTCACTAAGGCTATAATCTTC-3’, a total of 
450 bp.
  毬-actin as the internal reference: upstream 5’-
CAAGGCCAACCGCGAGAAGATG-3’, downstream 5’-
GTCCAGGGCGACGTAGCACAGC-3’, amplification length 
was 330 bp.
  They were amplified in the PCR instrument. After 1.5% 
agarose gel electrophoresis, the photo were observed with 
the DC2000 gel imaging analyzer. Compared with Marker, 
if there were positive bands at 409 bp, 450 bp and 330 
bp, it was determined as p53, mdm2 and 毬-actin mRNA 
positive expression respectively; If there was no positive 
band appears in the corresponding area, it was defined 
as negative. And the optical density value of the bands 
was analyzed by Quantity One software. The 毬-actin 
optical density values were used as internal reference for 
normalization of the absorbance value of p53 and mdm2 
mRNA. The relative content of p53 and mdm2 mRNA 
expression were obtained.
2.5. Proportion of p53, mdm2 cells in peripheral blood 
  PBS was diluted by an equal volume, peripheral blood 
mononuclear cells was obtained from human lymphocyte 
separation medium. Cell number was adjusted to 1暳10
6/mL, 
washed with PBS twice. After centrifuged at 1 000 rpm the 
supernatant was removed. 1:100 diluted mouse anti-human 
mdm2, p53 monoclonal antibody 100 毺L were added. They 
were bathed at room temperature for 30 min. After washed 
with PBS 2 times the supernatant was discarded, 1:20 
dilution of mouse monoclonal antibody FICT-IgG 100 毺L
marked mdm2 and p53 were added. They were bathed 
at 37 曟 for 30 min, then the supernatant was discarded, 
washed in PBS twice. One mL PBS liquid were added, and 
analyzed after 400 mesh screen filter. The proportion of p53, 
mdm2 cells was detected by flow cytometry.
2.6. Statistical analysis
  All data were analyzed by SPSS13.0 statistics software. And 
the data were expressed as mean暲SD values. t-test was 
applied in the comparison between two groups. Correlation 
analysis was analyzed with the Speraman correlation 
analysis. Kaplan-Meier method was used for prognosis 
analysis, P <0.05 was considered as statistical significance.
3. Results
3.1. RT-PCR detection of p53, mdm2 mRNA expression in 
different tissues
  Among 13 cases of normal oral mucosa, there was 1 case 
with p53 mRNA positive expression, with the positive rate 
as 7.7%; Among the simple oral leukoplakia, there were 
12 cases with p53 mRNA expression, with the positive rate 
as 27.3%; Among theno-simple oral leukoplakia, there 
were 15 cases with p53 mRNA expression, with positive 
rate as 33.3%; Among the leukoplakia cancer, there were 
21 cases with p53 mRNA expression, with the positive 
rate as 56.8%. The expression of mdm2 mRNA in normal 
oral mucosa, simple oral leukoplakia, no-simple oral 
leukoplakia and leukoplakia cancer were 0.0%, 6.8%, 
11.1%, 37.8%, respectively. The differences in expression of 
p53, mdm2 mRNA were statistically significant among the 
simple oral leukoplakia group, no-simple oral leukoplakia 
and leukoplakia cancer group (P<0.05). The differences 
in expression of p53, mdm2 mRNA were not statistically 
significant between simple oral leukoplakia group and the 
no-simple oral leukoplakia group (P>0.05) ( Figure 1).
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Figure 1. RT-PCR result.
p53: 409 bp, mdm2: 450 bp, 毬-actin: 330 bp.
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3.2. Proportion of p53, mdm2 in peripheral blood in each 
group were detected by flow cytometric analysis
  The frequencies of p53 in normal oral mucosa, simple oral 
leukoplakia, no-simple oral leukoplakia and leukoplakia 
cancer were (0.3暲0.1)%, (1.6暲0.9)%, (1.9暲1.1)%, (3.4暲
1.8)%, respectively. The frequencies of mdm2 in normal oral 
mucosa, simple oral leukoplakia, no-simple oral leukoplakia 
and leukoplakia cancer were (0.1暲0.1)%, (0.8暲0.6)%, (1.2暲
0.8)%, (1.2暲0.8)%. The expression of p53 and mdm2 cells in 
the leukoplakia cancer group was significantly higher than 
in the normal group, simple leukoplakia and abnormal white 
group (P<0.05).
3.3. Relationship of p53, mdm2 and clinical pathological 
features of patients with leukoplakia cancer
  For 37 patients with leukoplakia, p53 hada positive 
correlation with lymph node metastasis and pathological 
grading process, but had nothing to do with the skin lesions, 
clinical type and pathological grade (Table 1).
Table 1
 Relationship between P53, mdm2 and clinical pathological features of 
leukoplakia.
Groups n p53/毬-actin 
[M (P5-P95)]
mdm2/毬-actin 
[M (P5-P95)]
Position
Cheek   8 0.623(0.525-0.678) 0.463(0.325-0.498)
Ventral tongue 26 0.667(0.425-0.776) 0.478(0.345-0.567)
Other   3 0.594(0.486-0.588) 0.449(0.378-0.546)
Clinical classification
Homogeneous   7 0.612(0.558-0.738) 0.427(0.364-0.512)
Verrucous 11 0.642(0.525-0.766) 0.442(0.421-0.567)
Particle   9 0.607(0.496-0.776) 0.473(0.410-0.469)
Ulcer 10 0.614(0.425-0.733) 0.474(0.325-0.535)
Lymph node metastasis
without 17 0.546(0.425-0.688) 0.352(0.325-0.414)
with 20 0.743(0.578-0.884)* 0.524(0.480-0.567)*
Pathological grade
OSCC栺 12 0.570(0.476-0.768) 0.397(0.336-0.426)
OSCC栻 13 0.584(0.425-0.776) 0.434(0.325-0.460)
OSCC栿 12 0.677(0.457-0.884)
*
0.447(0.379-0.567) 
* Compared with the same group, P<0.05.
3.4. Correlation analysis of p53 and mdm2 expression
  A total of 21 cases had p53 mRNA positive expression, and 
12 had mdm2 mRNA expression. Among them, 12 cases had 
both p53 mRNA and mdm2 mRNA expression. Spearman 
rank correlation analysis showed positive correlation 
between p53 mRNA and mdm2 mRNA (r=0.636, P=0.006).
3.5. Survival analysis of p53 and mdm2 expression
  In 37 cases with leukoplakia cancer, if the p53 expression 
was positive, the median survival time was 8 months; if it 
was negative, the median survival time was 13.5 months, and 
the difference was significant statistically. Kaplan-Meier 
survival analysis curve revealed poor prognosis (Figure 2). 
If the mdm2 expression was positive, the median survival 
time was 7.5 months, if it was negative, the median survival 
time was 12 months, and the difference was significant 
statistically. And Kaplan-Meier survival analysis curve also 
suggestedpoor prognosis (Figure 3).
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Figure 2. Survival curve analysis of p53 mRNA.
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Figure 3. Survival curve analysis of mdm2 mRNA.
4. Discussion
   White spot (leukoplakia) refers to the white or off 
white keratosis lesions of plaque damage to the mucosal 
epithelium. This pathological plaque can not be erased, and 
there is a potential of the malignant transformation.
  Oral leukoplakia is a precancerous lesions in the oral 
mucosal epithelial. Dong et al[2] reported 17%-35% oral 
epithelial squamous cell carcinoma is the development of 
oral leukoplakia. So the treatment and prognosis of oral 
leukoplakia has great significance for the prevention of oral 
cancer. At present, the treatment of leukoplakia is still in the 
exploratory stage, so long-term follow-up is an important 
mean to monitoring the cancer patients, and it play a role in 
the prevention and treatment of malignant transformation of 
oral leukoplakia. The studies confirmed[3,4] that it may be the 
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maladjustment of epithelial network which made of a variety 
of cells and cytokines resulting in a white spot disease and 
thus carcinogenesis.
  p53 is a tumor suppressor gene which can induce cell 
growth arrest and the apoptosis differentiation and DNA 
repair. Wild-type p53 can inhibit cell division and 
proliferation, prevent cell malignant transformation. 
Mutant p53 can lead to tumorigenesis and invasion in 
vivo, prompting cells to produce anti-apoptotic and the 
capacity of anti-chemotherapy and anti-radiotherapy. 
Kovesi consider that the different expression of p53 in 
oral leukoplakia showed the increased genomic instability 
is consistent with oral leukoplakia cancer clinical 
manifestations. The mdm2 has a highly tumorigenicity and 
its amplification and expression can be found in a variety of 
tumors[5,6]. The main function of the mdm2 protein is direct 
bonding to acidic activation domain of the p53 protein and 
then forming the p53-mdm2 complex, thereby inhibiting 
wtp53 mediated transcriptional activation function. In this 
study, we observed the changes of serum p53 and mdm2 
expression levels in different types of patients with oral 
leukoplakia to explore its clinical significance.
  The result showed the expression of p53mRNA in normal 
oral mucosa, simple oral leukoplakia, no-simple oral 
leukoplakia and leukoplakia cancer were 7.7%, 27.3%, 
33.3%, 56.8%, respectively. The frequencies of p53 in normal 
oral mucosa, simple oral leukoplakia, no-simple oral 
leukoplakia and leukoplakia cancer were (0.3暲0.1)%, (1.6暲
0.9)%, (1.9暲1.1)%, (3.4暲1.8)%. The p53 positive expression 
rate were in an ascending order from normal oral mucosa, 
simple oral leukoplakia, no-simple oral leukoplakia to 
leukoplakia cancer. In patients with leukoplakia cancer, 
the p53 expression rate and intensity was higher in the 
pathological high-grade group than in the low-grade 
group. The p53 positive group was with significantly higher 
lymph node metastasis rate than the negative group, which 
suggested that abnormal p53 gene had a correlation with the 
occurrence of oral leukoplakia cancer, the differentiation of 
cancer cells and the malignant degree. Liu[7] also confirmed 
that p53 gene mutation result in the overexpression of 
p53 protein which has a correlation with the occurrence 
and development of oral precancerous lesions. The mdm2 
positive expression in leukoplakia cancer were significantly 
higher than in normal oral mucosa, simple oral leukoplakia, 
no-simple oral leukoplakia group, and the percentage of 
cells expression were in an ascending order with the lesions; 
The mdm2 expression in the lymph node metastasis was 
significantly higher than that without lymph node metastasis, 
which showed the mdm2 gene overexpression is more 
obvious in tumor metastasis. Jiang et al[8], Li also reported 
mdm2 tumor play an important role in the occurrence and 
development of tumors, there was a correlation between 
them.The Spearman rank analysis showed the p53 and 
mdm2 mRNA were positively correlated in patients with 
leukoplakia.P53 and mdm2 may participate in the process of 
the oral leukoplakia cancer and then induce the occurrence 
of oral leukoplakia cancer.
  There are numerous studies which confirmed the 
correlation between mutant p53 and mdm2.The mutant p53 
can not repair damaged DNA, at the same time the mdm2 
was activated and then inhibit the expression of the tumor 
suppressor gene p53, which leading to repeated cycles of 
mutant p53 and mdm2 chronic accumulation, and ultimately 
cause malignant transformation and proliferation of cells[9,10]. 
Wang[11] confirmed that p53, mdm2 protein expression are 
closely related to the occurrence and development of oral 
lichen planus and oral squamous cell carcinoma. After the 
follow-up, survival analysis showed that high expression 
of p53 and mdm2 has poor prognosis in patients with 
leukoplakia, which suggested that p53 and mdm2 can be the 
indicators of the  prognosis and predicting the outcome of 
oral leukoplakia cancer.
  In summary, the occurrence, development and prognosis 
of oral leukoplakia cancer may have a correlation with 
p53 and mdm2 gene expression. So P53 and mdm2 can 
be a biomarkers for the occurrence and development and 
prognosis assessment of leukoplakia cancer, which has a 
great significance for guiding the leukoplakia cancer clinical 
treatment and improve the prognosis.
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